Literature DB >> 32239050

CRISPR/Cas-directed programmable assembly of multi-enzyme complexes.

Samuel Lim1, Jiwoo Kim1, Yujin Kim1, Dawei Xu1, Douglas S Clark2.   

Abstract

We describe a versatile CRISPR/Cas-based strategy to construct multi-enzyme complexes scaffolded on a DNA template in programmable patterns. Catalytically inactive dCas9 nuclease was used in combination with SpyCatcher-SpyTag chemistry to assemble enzymes in a highly modular fashion. Five enzymes comprising the violacein biosynthesis pathway were precisely organized in nanometer proximity; a notable increase in violacein production demonstrated the benefits of scaffolding.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32239050     DOI: 10.1039/d0cc01174f

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  5 in total

Review 1.  Application of Nucleic Acid Frameworks in the Construction of Nanostructures and Cascade Biocatalysts: Recent Progress and Perspective.

Authors:  Gan Zhu; Ping Song; Jing Wu; Minglan Luo; Zhipeng Chen; Tingjian Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-01-07

2.  Metabolic pathway assembly using docking domains from type I cis-AT polyketide synthases.

Authors:  Xixi Sun; Yujie Yuan; Qitong Chen; Shiqi Nie; Jiaxuan Guo; Zutian Ou; Min Huang; Zixin Deng; Tiangang Liu; Tian Ma
Journal:  Nat Commun       Date:  2022-09-21       Impact factor: 17.694

Review 3.  Mechanistic Aspects for the Modulation of Enzyme Reactions on the DNA Scaffold.

Authors:  Peng Lin; Hui Yang; Eiji Nakata; Takashi Morii
Journal:  Molecules       Date:  2022-09-24       Impact factor: 4.927

Review 4.  Strategies to Build Hybrid Protein-DNA Nanostructures.

Authors:  Armando Hernandez-Garcia
Journal:  Nanomaterials (Basel)       Date:  2021-05-18       Impact factor: 5.076

Review 5.  Greatest Hits-Innovative Technologies for High Throughput Identification of Bispecific Antibodies.

Authors:  Tim Hofmann; Simon Krah; Carolin Sellmann; Stefan Zielonka; Achim Doerner
Journal:  Int J Mol Sci       Date:  2020-09-08       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.